Web10 dec. 2024 · Intuitively, the depth of response with myeloma therapy correlates with long-term outcomes. The relationship between CR and progression-free survival (PFS) and overall survival (OS) has been consistently demonstrated in a meta-analysis of trials using intensive therapy combined with older 3 or contemporary therapies. 4 Moreover, an … Web13 nov. 2024 · 653.Myeloma: Therapy, excluding Transplantation November 13, 2024 Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) …
Refractory multiple myeloma: analyzing MAMMOTH and STORM
Web13 nov. 2024 · In the retrospective MAMMOTH study, we reported the outcomes of patients with RRMM after they became refractory to dara, including a subset of patients who were TCR. We further analyzed the MAMMOTH dataset to generate a cohort of patients similar to patients in STORM in order to compare conventional care vs. Sd. Methods: cyber security top picks
Overall survival of patients with triple‐class refractory …
Web14 feb. 2024 · MAMMOTH Trial: Myeloma Outcomes Post Anti-CD38 MoAbs 06:16 ASH 2024 Conference Coverage ASH 2024 U.S. Myeloma CAR-T Consortium Real World Experience: Factor… Feat. H. Hashmi 12:11 SOHO 2024 Tenth Annual Meeting SOHO 2024 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Pro C… Feat. T. Martin … WebPatients and methods: A dataset of US patients refractory to an anti-CD38 monoclonal antibody (MAMMOTH) was used to identify patients who would meet eligibility for … Web14 jan. 2024 · Unfortunately, the MAMMOTH trial, which was looking at salvage therapies after daratumumab-based treatment had failed, showed substantially shorter progression … cyber security topics ppt